Subhajit Choudhury

机构：Novartis (India)

发表论文 3 篇 · 总被引 50 次 · h-index 2

代表论文

• Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis (2022 · JHEP Reports · 被引 48)
• First-in-human trial results of LNA043, a novel cartilage regenerative treatment for osteoarthritis (2021 · Osteoarthritis and Cartilage · 被引 2)
• P174 - Absorption, distribution, metabolism, and excretion of tropifexor, a potent FXR agonist for the treatment of NASH, following a single oral 1 mg dose of [14C]tropifexor in healthy male subjects (2020 · Drug Metabolism and Pharmacokinetics)